The evidence base on COVID-19 seeks to provide clinicians, program managers, and community members with credible up-to-date information on the relationship between viral hepatitis and liver disease with COVID-19. 

Synthesis on COVID-19 and liver disease:

Researchers and experts from across the world have been working rapidly to understand theinteraction of co-morbidities and COVID-19, including liver disease. In this synthesis published in April, Dr. Ward summarized the current status of the evidence on COVID-19 and liver disease.

Clinical Liver Disease series

The Coalition worked with Clinical Liver Disease, a journal of AASLD, to publish an 8 article series related to COVID-19 and liver disease.

Dr. Ward, Director of the Coalition, co-authored two of these articles:

Read the full series here.

Last day updated 26 May 2020